or Try an Advanced Search...

    Technical Analysis for BNR - Burning Rock Biotech Limited

    Grade Last Price % Change Price Change
    F 2.80 -0.36% -0.01
    BNR closed down 0.36 percent on Friday, November 1, 2024, on 15 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical BNR trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Down Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.36%
    Narrow Range Bar Range Contraction -0.36%
    Wide Bands Range Expansion -0.36%
    Gapped Down Weakness -0.36%
    Oversold Stochastic Weakness -0.36%
    Bullish Engulfing Bullish -1.06%
    Older End-of-Day Signals for BNR ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout 1 day ago
    Down 5% 1 day ago
    Down 3% 1 day ago
    Non-ADX 1,2,3,4 Bearish Retracement Entry 1 day ago
    Fell Below Previous Day's Low 1 day ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    BNR Chart by TradingView
    Basic chart:

    Profile

    Burning Rock Biotech develops cancer diagnostic treatment based on deoxyribonucleic acid (DNA). The company provides tumor gene detection, liquid biopsy, hereditary tumor gene detection, tumor benign, and precision clinical trail for lung cancer, breast cancer, colorectal cancer, prostatic cancer, thyroid cancer, and hereditary tumors. Burning Rock Biotech was founded in January 2014, and is based in Guangzhou, China with additional locations in Beijing and Shanghai, China.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Medicine Cancer Clinical Medicine Acid Oncology Tumor Breast Cancer Prostate Cancer Colorectal Cancer Lung Cancer Thyroid Biopsy Thyroid Cancer Hereditary Cancers

    Is BNR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 11 NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China
    Sep 27 Burning Rock CFO resigns
    Sep 27 Burning Rock Announces Changes to Management and Board of Directors
    Aug 23 Burning Rock Biotech GAAP EPS of -$0.14, revenue of $18.7M
    Aug 23 Burning Rock Reports Second Quarter 2024 Financial Results
    Aug 19 Burning Rock Biotech Limited Announces Expected Delisting of American Depositary Shares
    Jul 11 Companies Like Burning Rock Biotech (NASDAQ:BNR) Are In A Position To Invest In Growth
    Jun 3 Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
    May 30 Burning Rock Biotech joins hands with Bayer to expand precision cancer therapies portfolio
    May 30 Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
    See more BNR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 10.5
    52 Week Low 2.62
    Average Volume 34,569
    200-Day Moving Average 6.58
    50-Day Moving Average 3.71
    20-Day Moving Average 3.03
    10-Day Moving Average 2.85
    Average True Range 0.33
    RSI (14) 34.21
    ADX 13.27
    +DI 20.36
    -DI 20.18
    Chandelier Exit (Long, 3 ATRs) 4.66
    Chandelier Exit (Short, 3 ATRs) 3.64
    Upper Bollinger Bands 3.58
    Lower Bollinger Band 2.49
    Percent B (%b) 0.29
    BandWidth 35.78
    MACD Line -0.27
    MACD Signal Line -0.31
    MACD Histogram 0.0397
    Fundamentals Value
    Market Cap 287.49 Million
    Num Shares 103 Million
    EPS -0.97
    Price-to-Earnings (P/E) Ratio -2.89
    Price-to-Sales 0.15
    Price-to-Book 0.73
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.03
    Resistance 3 (R3) 3.00 2.90 2.99
    Resistance 2 (R2) 2.90 2.84 2.91 2.98
    Resistance 1 (R1) 2.85 2.81 2.88 2.88 2.96
    Pivot Point 2.75 2.75 2.76 2.76 2.75
    Support 1 (S1) 2.70 2.69 2.72 2.72 2.64
    Support 2 (S2) 2.60 2.66 2.61 2.62
    Support 3 (S3) 2.55 2.60 2.61
    Support 4 (S4) 2.57